5AM Venture Management »

Cidara Therapeutics shares owned by 5AM Venture Management

Quarter-by-quarter ownership of Cidara Therapeutics shares owned by 5AM Venture Management from 13F filings

Historical chart of 5AM Venture Management investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by 5AM Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by 5AM Venture Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $677k 57k 11.94

More positions owned by 5AM Venture Management

Skye Bioscience Com New (SKYE)
Entrada Therapeutics (TRDA)
Enliven Therapeutics (ELVN)
Dianthus Therapeutics (DNTH)
Celldex Therapeutics Com New (CLDX)
Biohaven (BHVN)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Praxis Precision Medicines I Com New (PRAX)
Erasca (ERAS)
Viking Therapeutics (VKTX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Tectonic Therapeutic
Miragen Therapeutics (VRDN)

View all positions for 5AM Venture Management

Top funds holding Cidara Therapeutics

Monashee Investment Management
BVF
Vanguard Group
Checkpoint Capital
Renaissance Technologies
Alethea Capital Management
5AM Venture Management
BlackRock
Geode Capital Management
Schonfeld Strategic Advisors
State Street Corporation
Us Bancorp
Russell Investments
Tower Research Capital
Manchester Capital Management

View all funds holding Cidara Therapeutics